How Japanese drugmaker Takeda’s $62b Shire deal reshapes pharma world

Takeda
FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon - RC1702FA7D40/File Photo

The rapidly changing global pharmaceutical landscape reached another milestone Tuesday as Takeda Pharmaceutical Co. completed its $62 billion acquisition of Shire Plc.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.